Caring for Cancer Patients During COVID-19 Global Pandemic: Risk Factors and Precautionary Principle
Overview
Affiliations
The current global pandemic COVID-19 challenges oncologists to reorganise cancer care in order to strikingly reduce hospital visits and admissions. Cancer patients are more susceptible to infections and likely to get severe consequences compared with other patients. Health-care facility services are quickly changing their systems and workflow in response to the global pandemic COVID-19 crisis. These alterations mitigate infection risks and give profound effects on crucial aspects of care, including patients with cancer. Here, we discuss the current situations and a roadmap for cancer care during the COVID-19 crisis. In the prevalence of global cancer and higher transmission of pandemic COVID-19, there is an urgent need to realise the effect of SARS-CoV-2 infection and their related life-threatening outcomes specifically for cancer patients.
Mohanna M, Herran M, Dominguez B, Sabbagh S, Msheik A, Itani M Support Care Cancer. 2024; 32(4):236.
PMID: 38506939 PMC: 10954847. DOI: 10.1007/s00520-024-08433-2.
Geukens T, Brandao M, Laenen A, Collignon J, van Marcke C, Louviaux I ESMO Open. 2022; 7(6):100610.
PMID: 36356416 PMC: 9639795. DOI: 10.1016/j.esmoop.2022.100610.
Health influence of SARS-CoV-2 (COVID-19) on cancer: a review.
Parise R, Li Y, Nadar R, Ramesh S, Ren J, Govindarajulu M Acta Biochim Biophys Sin (Shanghai). 2022; 54(10):1395-1405.
PMID: 36269132 PMC: 9828497. DOI: 10.3724/abbs.2022147.
Cytochrome c: Using Biological Insight toward Engineering an Optimized Anticancer Biodrug.
Delinois L, De Leon-Velez O, Vazquez-Medina A, Velez-Cabrera A, Marrero-Sanchez A, Nieves-Escobar C Inorganics (Basel). 2022; 9(11).
PMID: 35978717 PMC: 9380692. DOI: 10.3390/inorganics9110083.
Izadi-Najafabadi S, McQuarrie L, Peacock S, Halperin R, Lambert L, Mitton C Curr Oncol. 2022; 29(6):4199-4211.
PMID: 35735444 PMC: 9222084. DOI: 10.3390/curroncol29060335.